BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

742 related articles for article (PubMed ID: 36362359)

  • 1. The Molecular and Cellular Strategies of Glioblastoma and Non-Small-Cell Lung Cancer Cells Conferring Radioresistance.
    Alhaddad L; Osipov AN; Leonov S
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressor miR-29c regulates radioresistance in lung cancer cells.
    Arechaga-Ocampo E; Lopez-Camarillo C; Villegas-Sepulveda N; Gonzalez-De la Rosa CH; Perez-Añorve IX; Roldan-Perez R; Flores-Perez A; Peña-Curiel O; Angeles-Zaragoza O; Rangel Corona R; Gonzalez-Barrios JA; Bonilla-Moreno R; Del Moral-Hernandez O; Herrera LA; Garcia-Carranca A
    Tumour Biol; 2017 Mar; 39(3):1010428317695010. PubMed ID: 28345453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ITGB1 enhances the Radioresistance of human Non-small Cell Lung Cancer Cells by modulating the DNA damage response and YAP1-induced Epithelial-mesenchymal Transition.
    Li Y; Sun C; Tan Y; Zhang H; Li Y; Zou H
    Int J Biol Sci; 2021; 17(2):635-650. PubMed ID: 33613118
    [No Abstract]   [Full Text] [Related]  

  • 4. CLPTM1L induces estrogen receptor β signaling-mediated radioresistance in non-small cell lung cancer cells.
    Li H; Che J; Jiang M; Cui M; Feng G; Dong J; Zhang S; Lu L; Liu W; Fan S
    Cell Commun Signal; 2020 Sep; 18(1):152. PubMed ID: 32943060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CD44high Subpopulation of Multifraction Irradiation-Surviving NSCLC Cells Exhibits Partial EMT-Program Activation and DNA Damage Response Depending on Their p53 Status.
    Pustovalova M; Alhaddad L; Blokhina T; Smetanina N; Chigasova A; Chuprov-Netochin R; Eremin P; Gilmutdinova I; Osipov AN; Leonov S
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyploid/Multinucleated Giant and Slow-Cycling Cancer Cell Enrichment in Response to X-ray Irradiation of Human Glioblastoma Multiforme Cells Differing in Radioresistance and TP53/PTEN Status.
    Alhaddad L; Chuprov-Netochin R; Pustovalova M; Osipov AN; Leonov S
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-suppressive E3 ubiquitin ligase CHIP inhibits the PBK/ERK axis to repress stem cell properties and radioresistance in non-small cell lung cancer.
    Tan B; Zhang J; Wang W; Ma H; Yang Y
    Apoptosis; 2023 Apr; 28(3-4):397-413. PubMed ID: 36436119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
    Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
    Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines.
    Sui X; Geng JH; Yu HM; Li YH; Wang WH
    J Vis Exp; 2019 Aug; (150):. PubMed ID: 31498313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DDB2 increases radioresistance of NSCLC cells by enhancing DNA damage responses.
    Zou N; Xie G; Cui T; Srivastava AK; Qu M; Yang L; Wei S; Zheng Y; Wang QE
    Tumour Biol; 2016 Oct; 37(10):14183-14191. PubMed ID: 27553023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-365 enhances the radiosensitivity of non-small cell lung cancer cells through targeting CDC25A.
    Li H; Jiang M; Cui M; Feng G; Dong J; Li Y; Xiao H; Fan S
    Biochem Biophys Res Commun; 2019 Apr; 512(2):392-398. PubMed ID: 30902389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth inhibition and radiosensitization of glioblastoma and lung cancer cells by small interfering RNA silencing of tumor necrosis factor receptor-associated factor 2.
    Zheng M; Morgan-Lappe SE; Yang J; Bockbrader KM; Pamarthy D; Thomas D; Fesik SW; Sun Y
    Cancer Res; 2008 Sep; 68(18):7570-8. PubMed ID: 18794145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes.
    Gomez-Casal R; Bhattacharya C; Ganesh N; Bailey L; Basse P; Gibson M; Epperly M; Levina V
    Mol Cancer; 2013 Aug; 12(1):94. PubMed ID: 23947765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactant Protein B Suppresses Lung Cancer Progression by Inhibiting Secretory Phospholipase A2 Activity and Arachidonic Acid Production.
    Lee S; Kim D; Kang J; Kim E; Kim W; Youn H; Youn B
    Cell Physiol Biochem; 2017; 42(4):1684-1700. PubMed ID: 28743125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy diagnostic biomarkers in radioresistant human H460 lung cancer stem-like cells.
    Yun HS; Baek JH; Yim JH; Um HD; Park JK; Song JY; Park IC; Kim JS; Lee SJ; Lee CW; Hwang SG
    Cancer Biol Ther; 2016; 17(2):208-18. PubMed ID: 26901847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome c oxidase mediates labile iron level and radioresistance in glioblastoma.
    Ali MY; Oliva CR; Flor S; Goswami PC; Griguer CE
    Free Radic Biol Med; 2022 May; 185():25-35. PubMed ID: 35476930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporating cancer stem cells in radiation therapy treatment response modeling and the implication in glioblastoma multiforme treatment resistance.
    Yu VY; Nguyen D; Pajonk F; Kupelian P; Kaprealian T; Selch M; Low DA; Sheng K
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):866-75. PubMed ID: 25752402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-219a-5p enhances the radiosensitivity of non-small cell lung cancer cells through targeting CD164.
    Wei T; Cheng S; Fu XN; Feng LJ
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32364222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol enhances ionizing radiation-induced premature senescence in lung cancer cells.
    Luo H; Wang L; Schulte BA; Yang A; Tang S; Wang GY
    Int J Oncol; 2013 Dec; 43(6):1999-2006. PubMed ID: 24141489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44+ and CD133+ Non-Small Cell Lung Cancer Cells Exhibit DNA Damage Response Pathways and Dormant Polyploid Giant Cancer Cell Enrichment Relating to Their p53 Status.
    Pustovalova M; Blokhina T; Alhaddad L; Chigasova A; Chuprov-Netochin R; Veviorskiy A; Filkov G; Osipov AN; Leonov S
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.